Table 1 The characteristics of the patients.
Case No | Age (years) | Sex | Lens status | Initial VA (LogMAR) | Final VA (LogMAR) | Follow up duration (months) | Duration to 1st VH recurrence (months) | Recurrence interval | Total injection No. (months) | Average injection No. per year |
|---|---|---|---|---|---|---|---|---|---|---|
1 | 39 | F | Phakic | 0.2 | −0.07 | 60 | 8 | 4 | 9 | 2.1 |
2 | 41 | M | Phakic | 0.3 | 0.09 | 32 | 6 | 4 | 6 | 2.8 |
3 | 51 | M | Phakic | 0.39 | 0.22 | 24 | 4 | 3 | 5 | 3 |
4 | 58 | M | Pseudophakic | 0.69 | 0.04 | 28 | 6 | 3 | 7 | 3.8 |
5 | 68 | F | Pseudophakic | 1.0 | 0.3 | 36 | 5 | 4 | 7 | 2.7 |
6 | 33 | M | Phakic | 1.0 | 0 | 24 | 6 | 4 | 6 | 4 |
7 | 45 | M | Phakic | 0.69 | 0.15 | 32 | 4 | 4 | 7 | 3 |
8 | 31 | M | Phakic | 0.52 | 0.09 | 26 | 4 | 3 | 6 | 3.1 |
9 | 27 | F | Phakic | 0.39 | 0.09 | 28 | 7 | 3 | 6 | 3.4 |
10 | 62 | M | Pseudophakic | 0.3 | 0 | 26 | 5 | 4 | 5 | 2.9 |
11 | 56 | F | Pseudophakic | 0.39 | −0.07 | 35 | 6 | 4 | 7 | 2.9 |
12 | 50 | M | Pseudophakic | 1.69 | 0.22 | 28 | 5 | 3 | 6 | 3.1 |
Mean (± SD) | 46.8 (± 12.9) | 0.63 (± 0.43) | 0.09 (± 0.12) | 31.6 (± 9.8) | 5.5 (± 1.2) | 3.1 (± 0.5) |
